WHO ICTRP trial

A study to see the surgical outcomes and how safe and effective is the new laser…

CTRI/2014/09/005061 · Clinical Trials Registry India (CTRI) · Recruiting

Key facts

Trial ID CTRI/2014/09/005061
Public title A study to see the surgical outcomes and how safe and effective is the new laser machine MEL 90
Scientific title A study of safety, efficacy and refractive outcomes of MEL 90 excimer laser platform - MEL 90
Primary sponsor NETHRADHAMA SUPERSPECIALITY EYE HOSPITAL
Registry Clinical Trials Registry India (CTRI)
Recruitment status Recruiting
Study type Interventional
Phase Phase 1
Countries India
Conditions Health Condition 1: null- Patients with Myopia, Hypermetropia and Astigmatism undergoing treatment on the MEL 90 excimer laser platform
Interventions Intervention1: PRK (PHOTO REFRACTIVE KERATECTOMY): Under topical anaesthesia, a 9mm well will be applied firmly to the corneal surface, centered on the visual axis, and filled with 20% ethanol in balanced salt solution. After 30 seconds…
Registration date Sep 25, 2014
Target size 100
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations